PharmEcosse is a UK-based clinical-stage company progressing a novel therapeutic program that has the potential to become standard of care in the reduction and prevention of surgical scars.

For further information on becoming a clinical trial volunteer, please contact:

Clinical Trials Unit
PharmEcosse Ltd
Greendykes Steading

T +44 1356 648941


Latest News

Edzell, 7th February 2011 - PharmEcosse Ltd has received approval for a Phase 2 clinical study to explore the use of PE001 for the reduction or prevention of surgical scars in patients undergoing non-cancer bilateral breast surgery.  The trial will commence in January 2011 and is expected to report in the first quarter of 2013.

Photo of a woman with a large scar down the middle of her chest